Michael Landsittel, CHIEF FINANCIAL OFFICER at Blueprint Medicines Corp (BPMC), sold 27,468 shares at $87.09 ($2.4M) on 2024-03-15, disclosed to the SEC on 2024-03-19.
Scheduled sale ($2.4M) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.09 | 4,629 | $403K | 16.7% |
| 2 | $87.09 | 4,629 | $403K | 16.7% |
| 3 | $87.10 | 2,675 | $233K | 9.7% |
| 4 | $87.10 | 2,675 | $233K | 9.7% |
| 5 | $88.08 | 1,638 | $144K | 6.0% |
| 6 | $88.08 | 1,638 |
| $144K |
| 6.0% |
| 7 | $88.27 | 1,413 | $125K | 5.2% |
| 8 | $88.27 | 1,413 | $125K | 5.2% |
| 9 | $88.88 | 912 | $81K | 3.4% |
| 10 | $88.88 | 912 | $81K | 3.4% |
| 11 | $88.94 | 2,467 | $219K | 9.1% |
| 12 | $88.94 | 2,467 | $219K | 9.1% |
| Total | $87.78 avg | 27,468 | $2.4M | 100% |
| Filing → |
| BPMC | SELL | 2024-05-17 | $824K | — | Filing → |
| BPMC | SELL | 2024-05-06 | $1.1M | — | Filing → |
| BPMC | SELL | 2024-04-01 | $475K | — | Filing → |